---
figid: PMC7539765__ajcr0010-2909-f5
figlink: pmc/articles/PMC7539765/figure/fig05/
number: F5
caption: Probable interactions among TRIP13 and other molecules within clear cell
  Renal Cell Carcinoma. Overexpression of TRIP13 activates PI3K/AKT/mTOR pathway.
  AKT induces proteasome-mediated degradation of MAD2, the key component of SAC. Dysfunctional
  SAC leads to CIN and aneuploidy, which, together with mTOR, mediate cancer progression.
  TRIP13 together with TTC5 as a cofactor, inhibits p53 signaling and, consequently,
  suppresses the apoptosis. In cells with damaged DNA, TRIP13 functions to favor NHEJ
  over HR. NHEJ as more likely to be inaccurate, may contribute to cancer progression.
  TRIP13 also induces the expressions of E-cadherin and vimentin directly or through
  activation of the NOTCH signaling. The net effect is the promotion EMT, which is
  directly associated with gain of migratory and invasive capabilities. TRIP13 reduces
  the expressions of TGF-β1, TβRII and Smad3, the mediators of cellular senescence.
  The inhibition of TGF-β1/Smad3 signaling supports tumor growth. Decreased Smad3
  activity promotes EMT. SAC-spindle assembly checkpoint; CIN-chromosomal instability;
  NHEJ-non-homologous end joining; HR-homologous recombination; EMT-epithelial-mesenchymal
  transition.
pmcid: PMC7539765
papertitle: TRIP13 predicts poor prognosis in clear cell renal cell carcinoma.
reftext: Adam Kowalewski, et al. Am J Cancer Res. 2020;10(9):2909-2918.
pmc_ranked_result_index: '28308'
pathway_score: 0.8741736
filename: ajcr0010-2909-f5.jpg
figtitle: Probable interactions among TRIP13 and other molecules within clear cell
  Renal Cell Carcinoma
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7539765__ajcr0010-2909-f5.html
  '@type': Dataset
  description: Probable interactions among TRIP13 and other molecules within clear
    cell Renal Cell Carcinoma. Overexpression of TRIP13 activates PI3K/AKT/mTOR pathway.
    AKT induces proteasome-mediated degradation of MAD2, the key component of SAC.
    Dysfunctional SAC leads to CIN and aneuploidy, which, together with mTOR, mediate
    cancer progression. TRIP13 together with TTC5 as a cofactor, inhibits p53 signaling
    and, consequently, suppresses the apoptosis. In cells with damaged DNA, TRIP13
    functions to favor NHEJ over HR. NHEJ as more likely to be inaccurate, may contribute
    to cancer progression. TRIP13 also induces the expressions of E-cadherin and vimentin
    directly or through activation of the NOTCH signaling. The net effect is the promotion
    EMT, which is directly associated with gain of migratory and invasive capabilities.
    TRIP13 reduces the expressions of TGF-β1, TβRII and Smad3, the mediators of cellular
    senescence. The inhibition of TGF-β1/Smad3 signaling supports tumor growth. Decreased
    Smad3 activity promotes EMT. SAC-spindle assembly checkpoint; CIN-chromosomal
    instability; NHEJ-non-homologous end joining; HR-homologous recombination; EMT-epithelial-mesenchymal
    transition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRIP13
  - TTC5
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - TGFB1
  - NOTCH1
  - HES1
  - TP53
  - AKT2
  - AKT3
  - AKT1
  - TGFBR2
  - ADCY10
  - CDH1
  - MTOR
  - SMAD3
  - PDXP
  - CIN
  - aneuploidy
genes:
- word: TRIP13
  symbol: TRIP13
  source: hgnc_symbol
  hgnc_symbol: TRIP13
  entrez: '9319'
- word: TTC5
  symbol: TTC5
  source: hgnc_symbol
  hgnc_symbol: TTC5
  entrez: '91875'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TGF-B1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: Notch1
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: Hes1
  symbol: HES1
  source: hgnc_symbol
  hgnc_symbol: HES1
  entrez: '3280'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TBRII
  symbol: TBRII
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: SAC
  symbol: SAC
  source: hgnc_alias_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: CIN
  symbol: CIN
  source: hgnc_alias_symbol
  hgnc_symbol: PDXP
  entrez: '57026'
chemicals: []
diseases:
- word: CIN
  source: MESH
  identifier: D007674
- word: aneuploidy
  source: MESH
  identifier: D000782
figid_alias: PMC7539765__F5
redirect_from: /figures/PMC7539765__F5
figtype: Figure
---
